SCHEMBL13769000

SCHEMBL13769000

CCC12CCC3C4CCC(=O)C=C4[C@H](CO)CC3C1[C@H]1C[C@H]1C21CCC(=O)O1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 14/20 0.77
▸ AR P10275 14/20 0.77
▸ NR3C2 P08235 1/20 0.58
▸ CYP19A1 P11511 2/20 0.42
▸ LMNA P02545 3/20 0.40
▸ NR3C1 P04150 2/20 0.40
▸ ABCC4 O15439 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SHBG P04278 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12998927 1.00 PGR (0.77) PGRARNR3C2CYP19A1LMNA
SCHEMBL12998934 0.91 PGR (0.64) PGRARNR3C2CYP19A1LMNA
SCHEMBL12942949 0.90 PGR (0.62) PGRARNR3C2CYP19A1LMNA
SCHEMBL12943028 0.89 PGR (0.61) PGRARNR3C2LMNANR3C1
SCHEMBL12943045 0.87 PGR (1.00) PGRARNR3C2CYP19A1LMNA
SCHEMBL12998959 0.87 PGR (1.00) PGRARNR3C2CYP19A1LMNA
SCHEMBL16572801 0.87 PGR (1.00) PGRARNR3C2CYP19A1LMNA
SCHEMBL12942744 0.86 AR (0.60) PGRARNR3C2CYP19A1LMNA
SCHEMBL12942788 0.86 AR (0.60) PGRARNR3C2CYP19A1LMNA
SCHEMBL12998926 0.82 PGR (0.74) PGRARNR3C2LMNANR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009083272-A2 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-09 — — WO disclosed
Send feedback